BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17286159)

  • 1. The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris.
    Kaymak Y; Ilter N
    Dermatol Nurs; 2006 Dec; 18(6):576-80. PubMed ID: 17286159
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
    Sarifakioglu E; Onur O; Kart H; Yilmaz AE
    Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aggravation of acne by isotretinoin. 6 cases, predictive factors].
    Lehucher Ceyrac D; Chaspoux C; Sulimovic L; Morel P; Lefrancq H
    Ann Dermatol Venereol; 1998 Aug; 125(8):496-9. PubMed ID: 9747314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):224-31. PubMed ID: 10394434
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 12. Isotretinoin-induced nail fragility and onycholysis.
    Onder M; Oztaş MO; Oztaş P
    J Dermatolog Treat; 2001 Jun; 12(2):115-6. PubMed ID: 12243670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel management of isotretinoin-induced hypertriglyceridemia in an adolescent with severe acne.
    Beach RA; McQueen M; Wismer J
    Clin Pediatr (Phila); 2009 Jun; 48(5):551-4. PubMed ID: 19246414
    [No Abstract]   [Full Text] [Related]  

  • 15. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications].
    Egger SF; Huber-Spitzy V; Böhler K; Scholda C
    Ophthalmologe; 1995 Feb; 92(1):17-20. PubMed ID: 7719068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual irregularity during isotretinoin treatment.
    Kwon HJ; Lee JY; Cho BK; Park HJ
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):562-3. PubMed ID: 17374003
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of vitamin E to prevent dermal complications of isotretinoin.
    Goforoushan F; Azimi H; Goldust M
    Pak J Biol Sci; 2013 Jun; 16(11):548-50. PubMed ID: 24498826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Perspectives: Treating acne with isotretinoin.
    Pediatr Dermatol; 2015; 32(6):e324-5. PubMed ID: 26584707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.